Proteostasis Therapeutics secures $45 Mn in series A funding

Printer Print Email Email
Cambridge: Proteostasis Therapeutics (PTI) has announced that it has secured $45 million in series A financing to develop Proteostasis Regulator drugs as novel therapies to treat multiple genetic and degenerative disorders associated with protein homeostasis deficiencies. Investors included in the round were HealthCare Ventures, Fidelity Biosciences, New Enterprise Associates, Novartis Option Fund and Genzyme Ventures.

According to Andrew Dillin, Ph.D., co-founder of PTI, "The Company has established a map of the Proteostasis Network, leading to breakthroughs in understanding how stress on the network, including aging, environmental and cellular stresses, can lead to the onset of multiple serious diseases."

"Our initial funding of PTI over a year ago provided the basis for this emerging area of science to mature so that it now offers the promise of new drug candidates entering the clinic in the next 3-5 years," said Christopher Mirabelli, Ph.D., Managing Director of HealthCare Ventures and Chairman of the Board of PTI.

SPOTLIGHT
Entertainment
"Game of Thrones" author George R.R. Martin doesn't want season eight to be the final chapter of "..
US Indian
Facebook-owned photo messaging app Instagram has launched the beta version of its in-app sh..
Startup City
Youth are leading India's start-up ecosystem where the median age of founder-entrepreneurs..
Enterprise IT
Taking on streaming giants like Netflix and Hulu, Walt Disney Co. has announced it will laun..
Finance
The Reserve Bank of India injected a total liquidity of Rs 2.98 lakh crore in the market in 20..
Technology
Facebook-owned messaging app WhatsApp is still developing its previously announced "Vacatio..
Business
The Pentagon has selected Microsoft and Amazon Web Services (AWS, the cloud computing arm ..
Gadgets
Google Pixel and OnePlus smartphones are catching up and giving stiff competition to Samsu..
Career
Wiley, a global leader in research and education has announced a series of blended learning progr..